The UK became the first in the world to approve the pill and is now ready to start dishing it out to the population through a large study.
Around 10,000 people are expected to take the drug.
Run by the University of Oxford, the study is set to begin recruiting participants early next month, giving the country key data on how well the drug, molnupiravir, works in vaccinated people.
It will help the NHS plan how to roll out the antiviral treatments to the people who need them most,
It will provide another string to the UK’s bow in the fight against the virus.
A statement from the health department said: “Molnupiravir is a ground-breaking treatment that will help the most vulnerable and we are working at pace across the Government and with the NHS to set out plans to deploy it to patients through a national study as soon as possible.”
This is a breaking story. More to follow.